Drugs / O-(2-[F-18]Fluorethyl)-L-Tyrosin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00204295 | Jan 2004 → ? | brain neoplasm | University Hospital Muenster | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | O-(2-[F-18]Fluorethyl)-L-Tyrosin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00204295 ↗ |
| Known as | FET | “O-(2-[F-18]Fluorethyl)-L-Tyrosin (FET) - PET” NCT00204295 ↗ |